Hawaii Biotech: Phase I West Nile vax trial a success

Hawaii Biotech announced the successful completion of a Phase I clinical trial for its West Nile Virus vaccine. The recombinant sub-unit vaccine was found to be safe among healthy volunteers who had not been exposed to the virus. The company says it is preparing to proceed with additional safety studies in adults, and later plans to expand the studies to include elderly, juvenile and immunocompromised populations. Report